Business Wire

Align Technology Launches Align X-ray Insights, an AI Computer-Aided Detection Software, in the European Union and United Kingdom

Share

Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the launch in European Union countries and the United Kingdom of Align X-ray Insights, a new software-based (CADe*) computer aided detection solution that uses artificial intelligence (AI) to automatically analyze 2D radiographs.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250310448632/en/

Align X-ray Insights, an AI Computer-Aided Detection Software (Photo: Business Wire)

As part of the Align™ Digital Platform, Align X-ray Insights software is designed to support doctors to diagnose dental and oral health conditions, standardize analysis, streamline workflows, and improve patient engagement. A recent survey among early doctor users of the technology showed it helped 95% of them in communicating patient oral health conditions. Furthermore, 91% agreed that, when shown to patients, it improved patient trust and treatment acceptance of restorative procedures.1

After confirming diagnosis, doctors can use the Align X-ray Insights detailed report, automatic tooth charting, and color overlays of radiographic abnormalities for patient education and treatment planning. The AI detection functionalities include caries, periapical radiolucencies and periodontal bone loss and other conditions.

Align X-ray Insights – alongside Align™ Oral Health Suite, a comprehensive digital suite providing a clinical framework to empower engaging oral health conversations – further reinforces Align’s commitment to dental diagnostics by launching an X-ray diagnostic digital solution that can enhance the already available NIRI (Near Infra-Red Imaging) technology with iTero intraoral scanners and Oral Health Suite’s capabilities, with the objective to support and advance doctor treatment planning decisions and priorities, based on the patient records available.

“Align X-ray Insights represents a significant advancement in our digital restorative dentistry solutions with broader patient applicability,” said Simon Beard, Align Technology executive vice president and managing director, Europe, Middle East, and Africa (EMEA). “By integrating AI into radiographic analysis, we are empowering doctors with more precise diagnostic capabilities to improve their patient outcomes. This launch underscores our commitment to innovation and our ongoing efforts to expand our digital platform.”

“It is fantastic to see Align X-ray Insights being integrated into Align’s digital platform – bringing diagnostic AI capabilities to dentists all over the world. When we started our journey towards AI in dental diagnostics, we had hoped to improve patient outcomes via better diagnostics and treatment decisions,” said Professor Falk Schwendicke, director of the Dental Clinic at University of Munich. “Since then, we learned that further value lies in Align X-ray Insights by fostering patient communication, and facilitating comprehensive, systematic reporting. Combining this with the products and services already available to Align users is a leap forward for digital dentistry.”

Align Technology acquired dentalXrai GmbH in 2022 and has since worked on integrating its flagship product into the Align Digital Platform. Align X-ray Insights, a cloud-based software, can be accessed either from any desktop or tablet or through an integration with iTero. The desktop / tablet version becomes generally available in the European Union and United Kingdom as of March 25, 2025, and will be presented at the IDS tradeshow in Cologne, Germany on March 25-29, 2025. The integration of Align X-ray Insights with iTero™ intraoral scanners is underway and will commence limited market release soon. Align X-ray Insights received regulatory clearance in Europe, the UK, Canada and New Zealand, with further availability in other countries planned, pending approvals such as 510K clearance in the United States of America.

For more information, interested customers can visit www.alignxrayinsights.com. As part of the launch offer, doctors can benefit from a 60-day free-trial.

*CADe = computer-aided detection

  1. Based on a survey of n=24 doctors (19 GP / 5 orthodontists) using Align™ X-ray Insights in Europe (FR, UK, IT, DE, ES, NL, DK and LV) who were part of a limited market release. Doctors indicated their agreement with different statements using a 4-point scale from strongly agree to strongly disagree. Statements included “Align X-ray Insights, when shown to patients, increased treatment acceptance of restorative procedures.” (91% agreement), “Align X-ray Insights streamlines the dental diagnostic workflow, helping me save valuable time.” (70% agreement), “Align X-ray Insights contributes to higher trust when shown to patients during treatment option discussions.” (91% agreement) and “Align X-ray Insights helps me communicate patient oral health conditions and treatment options.” (95% agreement). Align X-ray Insights is intended to be used in conjunction with an evaluation by the doctor and should not be solely relied upon to make or confirm a diagnosis. Data on file at Align Technology as of January 2025.

About Align Technology, Inc.

Align Technology designs and manufactures the Invisalign® System, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 271.6 thousand doctor customers and is key to accessing Align’s 600 million consumer market opportunity worldwide. Over the past 28 years, Align has helped doctors treat approximately 19.5 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.

For additional information about the Invisalign System or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.

Invisalign, iTero, exocad, Align, and Align Digital Platform are trademarks of Align Technology, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250310448632/en/

Contacts

Align Technology
Madelyn Valente
(909) 833-5839
mvalente@aligntech.com

Zeno Group
Sarah Karlson
(828) 551-4201
sarah.karlson@zenogroup.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

AB InBev Reports First Quarter 2025 Results8.5.2025 08:03:00 EEST | Press release

Anheuser-Busch InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507671244/en/ AB InBev Strategic Priorities Regulated information1 “Beer is a passion point for consumers. The strength of the beer category and the continued momentum of our megabrands delivered another quarter of profitable growth. EBITDA increased at the top-end of our outlook and the ongoing optimization of our business drove Underlying EPS growth of 7.1%. The consistent execution of our strategy by our teams and partners drove a solid start to the year and reinforces our confidence in delivering on our outlook for 2025.” – Michel Doukeris, CEO, AB InBev Revenue +1.5% Revenue increased by 1.5% with revenue per hl growth of 3.7%. Reported revenue decreased by 6.3% to 13 628 million USD, impacted by unfavorable currency translation. 4.4% increase in combined revenues of our megabrands, led by Corona, which g

Rimini Street and ServiceNow Partner with Apsen Farmacêutica to Deliver a Next-Generation Vision of Enterprise-Wide Workflow Automation7.5.2025 19:55:00 EEST | Press release

Knowledge 2025 —Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, management and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today at ServiceNow’s annual customer and partner event, Knowledge 2025, announced that Apsen Farmacêutica, a Brazilian pharmaceutical manufacturer, has partnered with Rimini Street and ServiceNow to implement a next-generation vision of enterprise-wide workflow automation. This new vision will enable autonomy across the company to help respond faster to market changes, reduce information silos and improve operational efficiency. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507517040/en/ Rimini Street and ServiceNow Partner with Apsen Farmacêutica to Deliver a Next-Generation Vision of Enterprise-Wide Workflow Automation Apsen is prioritizing business needs above technology, leaning into a fl

Results from the VirTus Respiratory Research Ltd Human Rhinovirus Challenge Model Used to Advance Altesa BioSciences’ Lead Medicine into Advanced Clinical Trials7.5.2025 19:07:00 EEST | Press release

VirTus Respiratory Research Ltd, a leading respiratory-focused contract research organisation (CRO), today announced that results from their human rhinovirus challenge model in patients with chronic obstructive pulmonary disease (COPD) provided Altesa BioSciences with compelling evidence to advance their lead drug candidate, vapendavir, into large scale, late-stage clinical trials. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507489716/en/ Professor Sebastian Johnston https://www.prnewswire.com/news-releases/altesa-biosciences-details-positive-topline-vapendavir-results-from-phase-2-placebo-controlled-rhinovirus-challenge-study-in-copd-patients-302448650.html Rhinovirus infection is the cause of at least half of the acute respiratory deteriorations experienced by the millions of patients with chronic obstructive lung disease. “Before advancing vapendavir into clinical trials testing vapendavir on thousands of patients c

FlightSafety International Announces Major Expansion at Farnborough Airport7.5.2025 18:56:00 EEST | Press release

FlightSafety International (FSI), a global leader in aviation training, is pleased to announce the expansion of its facilities at Farnborough Airport, the home of British aviation and Europe’s leading airport for premium air travel connectivity, highlighting its commitment to enhancing aviation safety and training excellence in Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250506583636/en/ Rendering: arriving at FlightSafety International The new FSI centre is expected to open in the second quarter of 2027. Lease terms have been finalised and the planning application was submitted in January. Construction is scheduled to start in late 2025 and finish by early 2027. FSI has operated a training centre at Farnborough Airport since 2004. The new facilities will boost training capacity by 40-50%, enabling more aviation professionals access to FSI's world-class training programmes. The current facility is 4,680 square met

Verimatrix Positioned as a Leader and Ace Performer in the 2025 SPARK Matrix TM for In-App Protection by QKS Group7.5.2025 18:45:00 EEST | Press release

Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507970501/en/ Verimatrix positioned as a Leader in the 2025 SPARK Matrix™ for In-App Protection by QKS Group. Verimatrix has been recognized for its comprehensive in-app protection capabilities, earning strong ratings across both Technology Excellence and Customer Impact in the latest SPARK Matrix™. The company has also been named an Ace Performer a recognition given to vendors that demonstrate revenue growth potential, partnership strategy, and customer acquisition—all evaluated over the last one-year period or since the previous SPARK Matrix assessment. The QKS Group SPARK Matrix™ provides competitive analysis & ranking of the leading In-App Protection vendors. For more information about Verimatrix, visit: https://www.verimatrix.com SPARK MatrixTM: In-App Protection, Q1 2025: https://qksgroup.com/market-research/spark-matrix-in-app-protection-q1-2025-8413 V

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye